January 6, 2025, New York, New York, and Vatican City – On November 12, 2024, the Global Coalition on Aging and the Acton Institute brought together a diverse group of thought leaders—including senior clergy, scientists, patient advocates, and private sector innovators—at the Pontifical Academy of Sciences in Vatican City for a critical discussion on antimicrobial…

The decline in geriatric care leaves millions of older adults without specialized medical support, driven by low reimbursement rates and a lack of incentives for doctors to enter the field.

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

The Global Coalition on Aging (GCOA) last week issued a report calling on G7 countries to commit to funding pull incentives and making other investments in antibiotic innovation.

Common infections will kill millions if drug resistance through misuse of antibiotics is not curbed, says England’s ex-chief medical officer.